Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of cardiovascular diseases 2014-08, Vol.107 (8), p.476-478
Hauptverfasser:	Ağaç, Mustafa Tarık, Erkan, Hakan, Korkmaz, Levent
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Arrhythmia Agents - therapeutic use Arrhythmia suppression Brugada syndrome Brugada Syndrome - diagnosis Brugada Syndrome - drug therapy Brugada Syndrome - physiopathology Cardiovascular Cilostazole Defibrillators, Implantable Défibrillateur automatique implantable Electric Countershock - instrumentation Electrocardiography Heart Conduction System - drug effects Heart Conduction System - physiopathology Heart Rate - drug effects Humans Implantable cardioverter-defibrillator Internal Medicine Male Phosphodiesterase 3 Inhibitors - therapeutic use Recurrence Suppression des arythmies Syndrome de Brugada Tachycardia, Ventricular - diagnosis Tachycardia, Ventricular - drug therapy Tachycardia, Ventricular - physiopathology Tachycardie ventriculaire Tetrazoles - therapeutic use Treatment Outcome Ventricular tachycardia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!